ER+ breast tumors or cancer cell lines displayed higher ZNF217 expression levels compared to their ER- counterparts (p = 0.0004, p = 0.005 and p = 1 × 10−7 [51]; p = 0.009 and p = 0.0001 [82]). This evidence concerns the gene ZNF217 and breast neoplasm.